重性抑郁发作缓解后认知功能持续缺损的系统综述与荟萃分析
75个认知变量中55个(73%)存在显著缺损,多为小到中等效应,但逻辑记忆即刻与延迟回忆等三项长期记忆变量呈大效应缺损;既往抑郁发作次数可解释多数变量异质性。结论提示选择性注意、工作记忆与长期记忆缺损在缓解期持续存在,并随复发次数加重。
要点
- 重性抑郁发作缓解期在加工速度、视觉选择性注意、工作记忆、言语学习与执行功能等域存在小到中等缺损。
- 逻辑记忆即刻回忆、逻辑记忆延迟回忆与CANTAB模式识别潜伏期呈大效应缺损。
- 听觉注意、一般自传体记忆、非速度限制的抑制能力与智力功能在缓解者与对照间相当。
核心结论
- 重性抑郁发作缓解后,选择性注意、工作记忆与长期记忆缺损持续存在,并随既往发作次数增加而加重。
- 抑郁治疗(包括复发预防)需针对这些认知功能以优化预后。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、Embase、PsycARTICLES、PsycINFO、Cochrane Library等数据库1972年1月1日至2018年1月31日发表的文献。
- 采用随机效应模型计算18个标准认知域的效应量,并用混合效应亚组分析与元回归评估调节因素。
主要发现
- 75个认知变量中55个(73%)在重性抑郁发作缓解后存在显著缺损。
- 缺损效应量多为小(30个变量,40%)或中等(22个变量,29%)。
- 听觉注意、一般自传体记忆、非速度限制的抑制能力与非速度限制的智力功能在缓解者与匹配对照间无差异。
关键数值与推荐
- 认知缺损判定标准为缓解者与健康对照在18个标准认知域测验成绩的差异。
临床怎么用
- 临床评估抑郁缓解期患者时,应关注选择性注意、工作记忆与长期记忆等持续存在的认知缺损。
- 制定抑郁治疗方案(含复发预防)时,可考虑针对认知功能进行干预以改善长期预后。
- 询问既往抑郁发作次数有助于识别认知缺损风险更高的缓解期患者。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Substantial evidence suggests that cognitive deficits might persist after remission of a major depressive episode. However, results are inconsistent relative to the importance, pattern, severity, and moderating factors of this impairment. We aimed to determine how cognitive function following a major depressive episode compares with normal function, to specify the pattern and severity of persistent cognitive dysfunctions, and to examine the potential moderator effect of ten prespecified clinical and demographic variables. METHODS: We did a systematic review and meta-analysis of the published research. We searched systematically MEDLINE, Embase, PsycARTICLES, PsycINFO, the Cochrane Library, and relevant reviews identified by our database search, for research published from Jan 1, 1972, up to Jan 31, 2018, for studies of patients with past depression. We included all independent studies of patients who were assessed while in remission from a major depressive episode with at least one cognitive test, with inclusion of a healthy control group assessed with either the same test(s) as the major depressive episode group or with a standardised test with published age-stratified normative data. The main outcome was the difference in cognitive performance between major depressive episode remitters and healthy controls. Effect sizes were calculated using random-effects models for cognitive outcomes classified into 18 standard domains. Moderators of between-study variability were assessed using mixed-effects subgroup analyses and meta-regressions. FINDINGS: Of 10 126 citations identified by our search, 75 cognitive variables from 252 eligible studies (11 882 major depressive episode remitters and 8533 healthy controls) were included in our meta-analysis. Significant deficits following major depressive episode remission were observed in 55 (73%) of the 75 cognitive variables. These deficits (in the domains of processing speed, visual selective attention, working memory, verbal learning, and executive functioning), were generally small (30 [40%] of the 75 variables) or medium (22 [29%]) in size, although three long-term memory variables showed large deficits: g=-0·81 [95% CI -1·01 to -0·61] for logical memory immediate recall, g=-0·88 [-1·19 to -0·57] for logical memory delayed recall, and g=-0·84 [-1·18 to -0·50] for Cambridge Neuropsychological Test Automated Battery pattern recognition latency. Auditory attention, general autobiographical memory, inhibition ability unconstrained by speed, and intellectual functioning unconstrained by speed were equivalent between major depressive episode remitters and matched controls. The number of previous depressive episodes explained heterogeneity in the majority of variables (z=-2·06 [p=0·039] to z=-4·26 [p<0·0001]). INTERPRETATION: Deficits in selective attention, working memory, and long-term memory persist in remission from a major depressive episode and worsen with repeated episodes. Depression treatments, including relapse prevention, need to target these cognitive functions to optimise prognosis. FUNDING: None.
引用
- Semkovska M, Quinlivan L, O'Grady T, et al. Cognitive function following a major depressive episode: a systematic review and meta-analysis. Lancet Psychiatry. 2019. PMID: 31422920. doi:10.1016/S2215-0366(19)30291-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。